קונבריזה

Страна: Ізраїль

мова: іврит

Джерело: Ministry of Health

Активний інгредієнт:

BAZEDOXIFENE AS ACETATE 20 MG

Доступна з:

NEOPHARM LTD

Код атс:

G03XC02

Фармацевтична форма:

COATED TABLETS

Адміністрація маршрут:

PER OS

Виробник:

PFIZER IRELAND PHARMACEUTICALS

Терапевтична група:

BAZEDOXIFENE

Терапевтичні свідчення:

CONBRIZA is indicated for the treatment of postmenopausal osteoporosis in women at increased risk of fracture. A significant reduction in the incidence of vertebral fractures has been demonstrated; efficacy on hip fractures has not been established. When determining the choice of CONBRIZA or other therapies, including oestrogens, for an individual postmenopausal woman, consideration should be given to menopausal symptoms, effects on uterine and breast tissues, and cardiovascular risks and benefit

Дата Авторизація:

2013-04-01